Gene Editing: Detailed Explanation with Case Laws

1. Introduction

Gene editing, also known as genome editing, is a biotechnology technique used to make targeted changes to the DNA of a living organism. It can involve adding, removing, or modifying specific genetic sequences to study biological functions, treat inherited disorders, improve agricultural productivity, and develop new medical therapies.

Technologies such as CRISPR-Cas9, TALENs, and zinc-finger nucleases have expanded the possibilities of genetic research. CRISPR-Cas9 is particularly significant because it allows researchers to target selected DNA sequences using a programmable guide molecule and an associated enzyme.

Gene editing offers substantial benefits, but it also raises legal and ethical concerns involving patient safety, informed consent, genetic privacy, environmental protection, discrimination, and the possibility of transmitting genetic changes to future generations. The World Health Organization (WHO) therefore recommends robust governance and oversight of human genome editing.

World Health Organization

+1

2. Types of Gene Editing

A. Somatic Gene Editing

Somatic gene editing modifies cells other than reproductive cells. The resulting genetic changes generally affect the treated individual and are not inherited by their children.

For example, gene-editing therapies may be used to treat sickle-cell disease or certain other serious genetic disorders. Such interventions require rigorous clinical evaluation, regulatory authorisation, informed consent, and long-term safety monitoring.

B. Germline Gene Editing

Germline editing modifies reproductive cells, their precursors, or embryos. When an edited embryo is used to establish a pregnancy, the genetic change may be transmitted to subsequent generations.

This raises additional concerns because future individuals cannot consent to the intervention, and unintended genetic effects may persist across generations. The WHO has stated that proceeding with clinical applications of heritable human genome editing would be irresponsible at the present time.

World Health Organization

+1

C. Agricultural and Environmental Gene Editing

Gene editing can also be used in plants, animals, and microorganisms to develop disease resistance, improve crop characteristics, or investigate environmental applications. These uses may require biosafety assessments, environmental permissions, and monitoring for unintended ecological effects.

The applicable legal requirements depend on the organism, the intended use, the method employed, and the jurisdiction.

3. Legal and Regulatory Framework in India

India regulates gene-editing activities through several legal instruments rather than one comprehensive gene-editing statute.

A. Environment (Protection) Act, 1986: This Act provides the statutory foundation for regulating genetically engineered organisms and associated activities through the applicable rules and notifications.

B. Rules, 1989: The Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Micro-organisms/Genetically Engineered Organisms or Cells establish a biosafety framework for covered activities. Regulatory bodies include Institutional Biosafety Committees (IBSCs), the Review Committee on Genetic Manipulation (RCGM), and the Genetic Engineering Appraisal Committee (GEAC), according to their respective mandates.

C. Drugs and Cosmetics Act, 1940, and New Drugs and Clinical Trials Rules, 2019: These govern relevant investigational and therapeutic products, including gene-editing-based treatments where applicable. Clinical development and marketing authorisation require compliance with the relevant regulatory pathway.

India's Department of Biotechnology has also issued biosafety guidance relevant to recombinant DNA research and containment. Government material confirms that CRISPR-based therapies are subject to biosafety oversight and applicable drug regulation.

Press Information Bureau

4. Important Case Laws Relating to Gene Editing

A. Vellore Citizens’ Welfare Forum v. Union of India (1996)

Citation: (1996) 5 SCC 647.

The Supreme Court of India recognised the precautionary principle as an essential component of sustainable development. It emphasised that preventive action may be necessary even where scientific certainty regarding environmental harm is incomplete.

Relevance to gene editing: This principle is relevant to the environmental release of gene-edited organisms. Regulators should assess potential ecological consequences and require appropriate safeguards before permitting activities that may cause serious or irreversible harm.

B. A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999)

Citation: (1999) 2 SCC 718.

The Supreme Court highlighted the importance of scientific expertise in environmental decision-making, particularly where uncertainty exists and decisions may have serious consequences.

Relevance to gene editing: Regulatory authorities should rely on competent scientific assessment, independent review, and evolving evidence when evaluating the risks of genetically modified organisms and emerging biotechnology applications.

C. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017)

Citation: (2017) 10 SCC 1.

The Supreme Court recognised privacy as a fundamental right under Article 21 and the broader framework of Part III of the Constitution.

Relevance to gene editing: Genetic information can reveal highly personal information about individuals and their biological relatives. The constitutional protection of privacy is relevant to the collection, storage, disclosure, and use of genetic data. Genetic research and clinical programmes should therefore incorporate appropriate confidentiality and data-protection safeguards.

D. He Jiankui Gene-Edited Babies Case (China, 2019)

In December 2019, a court in Shenzhen convicted scientist He Jiankui and two collaborators for illegal medical practice associated with the use of gene editing in human embryos for reproductive purposes. He was sentenced to three years' imprisonment and fined three million yuan. The case involved serious concerns about unauthorised medical activity, ethical review, informed consent, and the safety of heritable genetic modification.

Taylor & Francis Online

+1

Relevance to gene editing: This case illustrates the consequences of conducting reproductive genome-editing interventions outside lawful and ethical oversight. It is a Chinese criminal proceeding, not a binding precedent in India, but it is an important international example of the risks of inadequate regulatory control.

5. Ethical and Legal Challenges

Gene editing raises several important concerns:

Safety: Unintended genetic changes and other adverse effects may occur.

Informed consent: Participants must understand the risks, uncertainties, and alternatives to proposed interventions.

Genetic discrimination: Genetic information must not be misused to disadvantage individuals in employment, insurance, or other settings.

Human dignity: Editing embryos for enhancement or non-medical preferences raises concerns about inequality and the possible creation of discriminatory genetic practices.

Environmental protection: Gene-edited organisms may create ecological risks requiring appropriate assessment and containment.

Accountability: Researchers, institutions, manufacturers, and regulators must comply with applicable legal and ethical requirements.

The WHO's 2021 governance framework recommends coordinated oversight, public engagement, international cooperation, and mechanisms to identify and address illegal, unethical, or unsafe genome-editing activities.

World Health Organization

+1

6. Conclusion

Gene editing represents a major advancement in biotechnology with potential applications in medicine, agriculture, and scientific research. However, its benefits must be balanced against risks to human health, genetic privacy, future generations, and the environment.

In India, the regulatory framework combines environmental biosafety legislation, biotechnology guidelines, and applicable pharmaceutical and clinical-trial regulations. Judicial principles concerning precaution, scientific expertise, and privacy help guide responsible governance, although the cited Indian judgments do not directly establish a comprehensive legal regime for CRISPR technology.

A sound approach requires evidence-based approval, ethical review, informed consent, long-term monitoring, and effective enforcement. The central legal objective is to encourage beneficial scientific innovation while ensuring that gene editing remains safe, accountable, and consistent with human rights and environmental protection.